N-acetyl-ß-D-glucosaminidase is predictive of mortality in chronic heart failure: a 10-year follow-up
C Strack, S Bauer, U Hubauer, E Ücer… - Biomarkers in …, 2021 - Future Medicine
Aim: The study focused on biomarkers of kidney injury as predictors of mortality in patients
with chronic heart failure (CHF) in a long-term follow-up (median 104 months) …
with chronic heart failure (CHF) in a long-term follow-up (median 104 months) …
Neutrophil gelatinase-associated lipocalin (NGAL): the laboratory perspective
The term acute kidney injury (AKI), which has now replaced the former expression acute
renal failure, designates an abrupt loss of kidney function, resulting in retention of urea and …
renal failure, designates an abrupt loss of kidney function, resulting in retention of urea and …
Beta-N-acetylglucosaminidase (beta-NAG) as a parameter in the diagnosis and evaluation of primary glomerular and tubulointerstitial kidney diseases
AC Hauser, V Fabrizii, K Derfler… - Wiener Klinische …, 1991 - europepmc.org
beta-N-acetylglucosaminidase (beta-NAG) and beta 2-microglobulin were assessed in two
cohorts of patients with glomerular or tubulointerstitial diseases respectively. While beta …
cohorts of patients with glomerular or tubulointerstitial diseases respectively. While beta …
[PDF][PDF] Mini–review: clinical and molecular markers in early diabetic nephropathy
M Reda, HK Amin - MOJ Drug Des Dev Ther, 2018 - academia.edu
Diabetes mellitus (DM) is the sixth leading cause of death worldwide because of its
complications. One of these deadly complications is diabetic nephropathy, the leading …
complications. One of these deadly complications is diabetic nephropathy, the leading …
Potential biomarkers of chronic kidney disease progression among kidney-derived proteins; a review
SP Kademani, P Nelaturi, V Bhat, S Sagar… - Journal of Renal Injury …, 2023 - journalrip.com
The incidence and mortality rate of kidney disease and its progression to end-stage disease
have predominantly increased worldwide. Other morbid conditions, such as diabetes and …
have predominantly increased worldwide. Other morbid conditions, such as diabetes and …
Urinary N-acetyl-beta-D glucosaminidase (NAG) level in idiopathic nephrotic syndrome
OP Mishra, P Jain, P Srivastava, R Prasad - Pediatric Nephrology, 2012 - Springer
Urinary N-acetyl-beta-D glucosaminidase (NAG) is a sensitive biomarker of renal
parenchymal disease. The aim of this study was to investigate variations in the levels of NAG …
parenchymal disease. The aim of this study was to investigate variations in the levels of NAG …
[图书][B] Proteomics in nephrology
V Thongboonkerd, JB Klein - 2004 - books.google.com
The novel discipline of proteomics has experienced a rapid growth in the recent past and
has a great potential for the future. Involving several fields, it offers various advantages: The …
has a great potential for the future. Involving several fields, it offers various advantages: The …
Novel urinary glycan profiling by lectin array serves as the biomarkers for predicting renal prognosis in patients with IgA nephropathy
C Kawakita, K Mise, Y Onishi, H Sugiyama… - Scientific reports, 2021 - nature.com
Abstract In IgA nephropathy (IgAN), IgA1 molecules are characterized by galactose
deficiency in O-glycans. Here, we investigated the association between urinary glycosylation …
deficiency in O-glycans. Here, we investigated the association between urinary glycosylation …
[PDF][PDF] Biomarkers for acute kidney injury
D Konukoglu - Int J Med Biochem, 2018 - jag.journalagent.com
Objectives: Acute kidney injury (AKI) is associated with both a number of adverse outcomes
and with morbidity and mortality. Therefore, early diagnosis of AKI is very important. Several …
and with morbidity and mortality. Therefore, early diagnosis of AKI is very important. Several …